Chemotherapy-Induced Toxicities: An Imaging Primer Journal Articles

abstract

• The Coronavirus Disease of 2019 (COVID-19) pandemic has caused significant delays in the delivery of cancer treatments in Canada. As cancer treatment and imaging volumes return to normal, radiologists will encounter more cases of chemotherapy-induced toxicities. These toxicities have varied appearances on imaging, and can affect multiple organ systems. The purpose of this review is to offer a unified resource for general radiologists regarding the imaging appearances of chemotherapy-induced toxicities.

authors

• Patil, Nikhil S
• Larocque, Natasha
• Van Der Pol, Christian Balth
• Torres, Carlos
• Raptis, Demetrios A
• Patlas, Michael N

status

• published 

publication date

• May 2023

has subject area

• 1103 Clinical Sciences (FoR)
• Antineoplastic Agents (MeSH)
• COVID-19 (MeSH)
• Canada (MeSH)
• Diagnostic Imaging (MeSH)
• Humans (MeSH)
• Nuclear Medicine & Medical Imaging (Science Metrix)

published in

• Canadian Association of Radiologists Journal  Journal

keywords

• Antineoplastic Agents
• COVID-19
• Canada
• Diagnostic Imaging
• Humans
• cancer
• chemotherapy
• chemotoxicity
• immune checkpoint inhibitor

Digital Object Identifier (DOI)

• 10.1177/08465371221120263

PubMed ID

• 35968850

start page

• 432

end page

• 445

volume

• 74

issue

• 2